Author

Anna Idelevich

Dana-Farber Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Alison W. Tisdale· 1 shared Bing ShuiiD· 1 shared Christian William JohnsoniD· 1 shared Deborah K. MorrisoniD· 1 shared Elizabeth M. Terrell· 1 shared Eve O’DonoghueiD· 1 shared Joshua CookiD· 1 shared Kevin M. HaigisiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alison W. Tisdale

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cooperativity between Ras pathway mutations in colonic tumorigenesis

Christian William Johnson, Anna Idelevich, Bing Shui, Alison W. Tisdale, Eve O’Donoghue, Joshua Cook, Shannon Hull, Moon Hee Yang, Shikha Sheth, Elizabeth M. Terrell, Stefânia Bovo Minto, Deborah K. Morrison, Scott Kopetz, Rona D. Yaeger, Kevin M. Haigis

This study shows that specific KRAS mutations, like A59E, cooperate with other genetic alterations in CRC and affect response to EGFR inhibitors.

bioRxiv · Sep 5, 2025 · PreprintCancer Biology